John M. Maraganore
2021
Compensation breakdown
| Non-Equity Incentive Plan | $1,095,720 |
|---|---|
| Option Awards | $7,861,410 |
| Salary | $948,500 |
| Other | $271,055 |
| Total | $10,176,685 |
Maraganore received $7.9M in option awards, accounting for 77% of the total pay in 2021.
Maraganore also received $1.1M in non-equity incentive plan, $948.5K in salary and $271.1K in other compensation.
Rankings
In 2021, John M. Maraganore's compensation ranked 1,015th out of 12,397 executives tracked by ExecPay. In other words, Maraganore earned more than 91.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,015 out of 12,397 | 92nd |
Division Manufacturing | 340 out of 5,492 | 94th |
Major group Chemicals And Allied Products | 114 out of 2,367 | 95th |
Industry group Drugs | 97 out of 2,090 | 95th |
Industry Pharmaceutical Preparations | 65 out of 1,537 | 96th |
Pay ratio
| John M. Maraganore's Pay | $10,176,685 |
|---|---|
| Median Employee's Pay | $231,163 |
| Pay Ratio | 44to 1 |
In 2021, the annual total compensation of John M. Maraganore was $10,176,685.
The annual total compensation of the median employee at Alnylam Pharmaceuticals was $231,163.
The ratio of John M. Maraganore's pay to the pay of median employee was therefore 44 to one.
Maraganore's colleagues
We found four more compensation records of executives who worked with John M. Maraganore at Alnylam Pharmaceuticals in 2021.
2021
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
2021
Tolga Tanguler
Alnylam Pharmaceuticals
Executive Vice President, Chief Commercial Officer
2021
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
2021
Jeffrey Poulton
Alnylam Pharmaceuticals